Bristol Myers Squibb (BMY) Change in Taxes (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Change in Taxes data on file, last reported at $187.0 million in Q1 2026.

• Change in Taxes for Q1 2026 came in at $187.0 million, up 246.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $129.0 million (up 106.1% YoY), and the FY2025 annual result was -$4.0 million, up 99.68% from the prior year.
• Change in Taxes rose to $187.0 million in Q1 2026 per BMY's latest filing, from -$324.0 million in the prior quarter.
• Over five years, Change in Taxes peaked at $1.0 billion in Q4 2023 and troughed at -$2.1 billion in Q2 2023.
• A 5-year average of -$182.5 million and a median of $54.0 million in 2025 frame the typical range for Change in Taxes.
• The sharpest annual moves came in 2023 and 2025: Change in Taxes tumbled 786.67% in 2023, then surged 354.89% in 2025.
• A 5-year view of Change in Taxes shows it stood at -$1.1 billion in 2022, then soared by 193.8% to $1.0 billion in 2023, then sank by 88.41% to $121.0 million in 2024, then tumbled by 367.77% to -$324.0 million in 2025, then soared by 157.72% to $187.0 million in 2026.
• Business Quant data shows BMY's Change in Taxes at $187.0 million in Q1 2026, -$324.0 million in Q4 2025, and $887.0 million in Q3 2025.